Skip to main content

Review

Biomarkers of Coronary Artery Disease Differ Between Asians and Caucasians in the General Population

Authors
  • Crystel M. Gijsberts
  • Hester M. den Ruijter
  • Folkert W. Asselbergs
  • Mark Y. Chan
  • Dominique P.V. de Kleijn
  • Imo E. Hoefer

Abstract

Coronary artery disease (CAD) markers have not been thoroughly investigated among Asians. The incidence of CAD, however, is rising rapidly in Asia. In this review, we systematically discuss publications that compare CAD biomarkers between Asians and Caucasians in the general population. A PubMed search yielded 5,570 hits, containing 59 articles describing 47 unique cohorts that directly compare Asians with Caucasians. Ten biomarkers were taken into account for this review: total cholesterol; triglycerides; highdensity lipoprotein cholesterol; low-density lipoprotein cholesterol; C-reactive protein; glucose; insulin; glycated hemoglobin; fibrinogen; and plasminogen activator inhibitor-1. Triglycerides were 1.13-fold higher in South Asians than in Caucasians, and insulin levels were 1.33-fold higher. In Japanese and Chinese subjects, lower C-reactive protein levels were reported: 0.52 and 0.36-fold, respectively. Ethnicityspecific prognostic measures of CAD biomarkers were rarely reported. CAD biomarker levels differ between Asians and Caucasians and among Asian ethnic groups in population-based cohorts. The ethnicity-specific prognostic value of CAD biomarkers is yet to be determined.

Highlights

  • Biomarkers for coronary artery disease differ between Asians and Caucasians.
  • Biomarkers for coronary artery disease differ among Asian ethnic groups.
  • Ethnicity-specific prognostic values of biomarkers have not been studied.
  • Ethnicity-specific prognostic values of biomarkers are needed for risk prediction.
Published on Dec 1, 2015
Peer Reviewed